- Hologic press release (NASDAQ:HOLX): Q3 Non-GAAP EPS of $0.95 beats by $0.25.
- Revenue of $1B (-14.5% Y/Y) beats by $103.29M.
- Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency.
- Company Again Increases Full-Year Revenue and EPS Guidance.
- Cash flow from operations remained very strong in the third quarter at $330.6 million.
Hologic Non-GAAP EPS of $0.95 beats by $0.25, revenue of $1B beats by $103.29M
Recommended For You
About HOLX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
HOLX | - | - |
Hologic, Inc. |